PRECISIONscientia Named a 2022 Best Places to Work Honoree for Third Consecutive Year

The Business Journal reveals PRECISIONscientia as a 2022 Best Places to Work for third consecutive year

First published in the Philadelphia Business Journal

By Lisa Dukart  –  Associate Editor, Philadelphia Business Journal Jun 11, 2022

There’s no doubt that work has significantly changed over the past two years. As it continues to evolve, one thing remains constant: Employees want to work for companies whose values and culture align with their own.

That’s increasingly true for younger generations like millennials and Generation Z. A socially conscious group, Gen Z in particular seeks companies committed to diversity, equity and inclusion, environmental responsibility and social causes.

Such commitments are increasingly being integrated into company cultures. Where once free snacks, events and on-site amenities were the height of workplace perks, today they’re being supplanted – at least in part – by paid volunteer time off, flexible schedules and skills training.

The Business Journal once again partnered with Quantum Workplace to identify Greater Philadelphia’s Best Places to Work. This year’s list includes 76 companies from across the region, ranked by employee feedback.

Nominated by the public, employees from each company were asked to complete Quantum’s online survey. Responses from each completed survey were then compiled and evaluated. Companies are ranked and winners chosen in each of the categories by their composite score.

The survey measures each company’s culture and takes into consideration compensation, benefits and trust in senior leadership.

Consisting of five categories based on company size – micro, small, medium, large, and extra-large – the winners in each category will be revealed in a special print publication in late July.

Here are all of the 2022 Best Places to Work honorees for large companies, listed in alphabetical order:

Large (100-499 employees)

  • AnnieMac Home Mortgage – Mount Laurel, New Jersey
  • Baker Tilly US – Philadelphia
  • Clark Capital Management Group – Philadelphia
  • Gallagher – Radnor
  • Green Lawn Fertilizing/Green Pest Solutions – West Chester
  • Greenphire – King of Prussia
  • IMS Technology Services – Garnet Valley
  • Iovance Biotherapeutics – Philadelphia
  • JLL – Philadelphia
  • Labor First – Mount Laurel, New Jersey
  • Miles Technologies – Lumberton, New Jersey
  • Morgan Stanley – Philadelphia
  • NFP – Warrington
  • PeopleShare – Collegeville
  • Precis – Ambler
  • PRECISIONscientia – Yardley
  • Scully Co. – Jenkintown
  • Slalom – Philadelphia
  • Spring EQ – Philadelphia
  • Your Part-Time Controller – Philadelphia

Looking to join a team of passionate scientific storytellers? Check out our open roles .

The Precision Value & Health family of brands is now Precision AQ

Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.

Our global offerings include:

  • Commercialization research, strategy and product planning
  • HEOR
  • Market access
  • Advertising, Branding & PR
  • Medical communications
  • Investor relations and external communications
  • Learning & development
  • Data and product solutions (Access Genius, Navigator365, OncoGenius, EHR Solutions, KOL/DOL Map)

Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.

To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ


Accelerating clinical research and development through the combined power of trials, labs, and data science.

Demonstrating the value of life-science innovations with evidence and real-world expertise.